Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
Recruiting · NCT06960798 · Observational (researchers observe without assigning treatment) · Lead sponsor: University of Oklahoma
View the official record on ClinicalTrials.gov →Interventions studied
Bio-specimen CollectionBlood Draw
What this trial is about
The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.
Who can take part
Age range
18 Years to 100 Years
Sex
Male
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Written informed consent signed and dated by the patient prior to the performance of any study-specific procedures, sampling, or analyses.
- At least 18 years-of-age at the time of signature of the informed consent form (ICF).
- Patients who self-identify as Native American.
- Patients with a pathologically proven diagnosis of PC (any stage).
- Availability of most recent archived tumor samples.
Exclusion criteria
- Patients not of Native American descent or identity.
- Patient does not have archival tissue available.
Where it is running
1 location listed across 1 US state.
- OU Health Stephenson Cancer Center - Oklahoma City, Oklahoma, United States